Skip to content

A study to assess energy healing using prana as an add-on therapy for Anxiety.

A prospective, randomised, double-blind clinical trial of Pranic Healing as adjunct therapy in patients with anxiety. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010646
Enrollment
100
Registered
2017-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Anxiety

Interventions

Intervention1: Intervention: Receives treatment as usual for Anxiety along with 20 minutes of complementary therapy of Pranic Healing session once a week for 4 weeks and a booster session on 6th week

Sponsors

World Pranic Healing Foundation India
Lead Sponsor
World Pranic Healing Foundation India Research Centre
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All subjects with DSM V Axis I diagnosis of Anxiety Disorders that was ascertained using the Structured Diagnostic Interview for DSM V (SCID) interview format. Patients having a minimum baseline total Hamilton Anxiety Rating (HAM-A) score >= 9. These will include: separation anxiety disorder, selective mutism, specific phobia, social phobia, panic disorder, agoraphobia, and generalized anxiety disorder, Obsessive-Compulsive Disorders (obsessive-compulsive disorder, body dysmorphic disorder, hoarding disorder, trichotillomania, and excoriation disorder) and trauma and Stressor-Related Disorders (reactive attachment disorder, disinhibited social engagement disorder, PTSD, acute stress disorder, and adjustment disorder). Patients with other co-morbid DSM V Axis I disorders (e.g., minor depression) will not be excluded from the trial if the co-morbid condition does not constitute the primary disorder.

Exclusion criteria

Exclusion criteria: Patients will be excluded from the trial if they have a current diagnosis of major depressive disorder, Other exclusion criteria are patients receiving treatment for thyroid disorders (T3, T4 and TSH), unstable medical condition, epilepsy, mental retardation, memory problem, sensory impairment, pregnancy, hepatic or renal insufficiency and malignancy.

Design outcomes

Primary

MeasureTime frame
Change in Anxiety score as per HAM-A Rating.Timepoint: Day 1, Day 15, Day 30, Day 60

Secondary

MeasureTime frame
The Hamilton Rating Scale for Depression Measuring Health and Disability using WHO DAS II Quality of Life Salivary cortisol Pittsburgh Sleep Quality Index (PSQI) Patient Health Questionnaire (PHQ-9) Pranic Energy Perception Questionnaire (PEPQ) Body Mass index Pulse rateTimepoint: Day1,8,15,22,30,45,60

Countries

India

Contacts

Public ContactSrikanth Jois Nagaraja

Mysore Medical College and Researcher Institute

drrajgopal@gmail.com0821-2520512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026